AzTrials
AzTrials

Subfertility, FemaleNCT05137964

A Cross Sectional Evaluation of Vitamin D Status and Ovarian Reserve Markers

An observational study of Subfertility, Female, run by Australian Concept Medical Center.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluation of the association between vitamin D (VD) deficiency and ovarian reserve markers in a group of Pakistani sub fertile women was conducted Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Subfertility, Female
What is being tested?
Vitamin D
How many people
199 participants
Where
No sites listed yet
Study dates
1 Aug 2016to 1 Jul 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Adult

Study population: Pakistani female patients aged 18 to 45 years, presenting with primary and/or secondary subfertility

Who may be able to join

  • Clinical diagnosis of primary and/or secondary subfertility

Who cannot join

  • Patients with missing data i.e., BMI, duration of subfertility, age, AMH, 25-hydroxyvitamin D (25-OHD), AFC and FSH.

About this study

Official title: Is Vitamin D The Missing Piece of the Subfertility Puzzle in Pakistani Women? A Cross Sectional Evaluation of Vitamin D Status and Ovarian Reserve Markers

Evaluation of the association between vitamin D (VD) deficiency and ovarian reserve markers in a group of Pakistani sub fertile women was conducted

Read the detailed description

Objective

This study was conceived with the objective to assess ovarian reserves in presence of vitamin D deficiency (VDD) in a select group of Pakistani sub fertile women, presenting at a specialized fertility centre. The measurements of antral follicle count (AFC), Serum Anti-Müllerian hormone (AMH), Serum Follicle-stimulating hormone (FSH) and Serum Vitamin D (VD) levels were the main tools used for the assessment of ovarian reserve.

Materials \& Methods A retrospective cross-sectional study was conducted at the Australian Concept Medical Centre after approval from the institutional ethical review committee. All female patients aged 18 to 45 years, presenting with primary and/or secondary subfertility, at the Australian Concept Medical Centre in Karachi, Pakistan from August 2016 to July 2021 were included in the study (n=301). Inclusion criteria was focused on subjects labelled as sub fertile by the consultant gynecologist, based on the criteria of failed to conceive after 12 months of no contraceptive use. Patients with missing data i.e., BMI, duration of subfertility, age, AMH, 25-hydroxyvitamin D (25-OHD), AFC and FSH were further excluded.

The Biochemical analysis was performed at the section of Chemical Pathology, department of Pathology and Laboratory Medicine, Aga Khan University, Karachi. 25-OHD was analyzed by a chemiluminescence assay on the liaison XL (DiaSorin) analyzer. AMH was measured using electro chemiluminescence assay on the Roche Diagnostic e411 analyzer. While FSH quantification was done using ADVIA Centaur FSH assay from Siemens Medical Solutions Diagnostics USA. The internal and external quality assurance was ensured according to the institutional protocol. Moreover, the laboratory is accredited by the College of American Pathologists (CAP) and Joint Commission international, ensuring external quality assurance.

AFC was determined through a transvaginal 2D ultrasound of the pelvis. To reduce the bias, all ultrasound scans were conducted in the center using the same machine (Model 6v1: Sonoscape) and vaginal probe (3.5 Hz). Before ultra sound procedure, patients were directed to empty bladder and a standard ultrasound technique was used. Two values were obtained, one for each ovary, and an average was taken to obtain a final value.

The data of all eligible patients was recorded in the pre-defined Performa designed for this study. The Kruskal-Wallis Test and one way ANOVA was applied to report the distribution of the data. The correlation between the categorical variables (25-OHD levels with AFC and AMH) was assessed using the Chi-Square test and Spearman Correlation. Comparison was based on 25-OHD levels grouped into three categories: deficiency (<20ng/ml), insufficiency (21-29 ng/ml) and sufficiency (>30ng/ml). AMH was categorized as low (<1 ng/ml), low normal (1-2 ng/ml), normal (2-4 ng/ml), and high (>4 ng/ml). The third variable, AFC, was also classified into very low (<6), low normal (6-8), normal (8-10), high normal (10-12), very high (>12). The p value <0.05 was considered statistically significant. The statistical analysis was performed using the statistical software IBM SPSS Statistics for Windows version 23.0 (IBM Corp. Released 2015. Armonk, NY: IBM Corp).

Being tested
Vitamin D
Keywords
subfertile, female
Medical subject headings
Infertility, Female

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vitamin DDiagnostic test

    Also called Serum AMH, 25-hydroxyvitamin D (25-OHD), FSH and Antral Follicle Count (AFC) via ultra sound

    Serum Biochemical routine lab workup and gynaecological ultra sound AFC

Study groups in NCT05137964
Study groupRoleWhat they receive
Vitamin D Deficientdeficiency (<20ng/ml)
Receives: Diagnostic Test: Vitamin D
Vitamin D Sufficientsufficiency (>30ng/ml)
Receives: Diagnostic Test: Vitamin D

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation

    To address gaps in local data, this study was conducted to explore the association between VDD and ovarian reserve, via measurements of AFC, AMH, FSH and 25-hydroxy vitamin D (25-OHD) in Pakistani women.

    Measured: Aug 2016 to July 2021

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2021
  2. Study start1 Aug 2016
  3. Primary completion1 Jul 2021
  4. Study completion1 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
199 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05137964
Sponsor's protocol ID
2021-07-01-Uzma Imran
Status last verified
Nov 2021
First submitted
5 Nov 2021
Last updated
30 Nov 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Subfertility, Female, run by Australian Concept Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation (time frame: Aug 2016 to July 2021). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in